Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  259 results for ""Adamantane""

Your Filters

Geographic : united states
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Dapagliflozin or Saxagliptin in Pediatric Type 2 Diabetes.

  • Authors : Shehadeh N; Rambam Health Care Campus, Haifa, Israel.; Bar-Ilan University, Safed, Israel.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Dipeptides*

  • Source: NEJM evidence [NEJM Evid] 2023 Dec; Vol. 2 (12), pp. EVIDoa2300210. Date of Electronic Publication: 2023 Oct 04.Publisher: NEJM Group, a division of the Massachusetts Medical Society Country of Publication: United States NLM ID: 9918317485806676

Record details

Read More Add to Saved list
×
Academic Journal

High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents--United States, 2005-06 influenza season.

Subjects: Drug Resistance, Viral*; Adamantane/Adamantane/Adamantane/*therapeutic use ; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use

  • Source: MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2006 Jan 20; Vol. 55 (2), pp. 44-6.Publisher: U.S. Centers for Disease Control Country of Publication: United States NLM ID: 7802429 Publication Model: Print

Record details

Read Online Read More Add to Saved list
×
Academic Journal

The genesis and spread of reassortment human influenza A/H3N2 viruses conferring adamantane resistance.

  • Authors : Simonsen L; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Viboud C

Subjects: Adamantane/Adamantane/Adamantane/*pharmacology ; Antiviral Agents/Antiviral Agents/Antiviral Agents/*pharmacology ; Drug Resistance, Viral/Drug Resistance, Viral/Drug Resistance, Viral/*genetics

  • Source: Molecular biology and evolution [Mol Biol Evol] 2007 Aug; Vol. 24 (8), pp. 1811-20. Date of Electronic Publication: 2007 May 23.Publisher: Oxford University Press Country of Publication: United States NLM ID: 8501455 Publication Model: Print-Electronic

Record details

Read More Add to Saved list
×
Academic Journal

Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States.

  • Authors : Bright RA; Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Influenza Branch, Atlanta, Ga, USA.; Shay DK

Subjects: Adamantane/Adamantane/Adamantane/*pharmacology ; Antiviral Agents/Antiviral Agents/Antiviral Agents/*pharmacology ; Drug Resistance, Viral/Drug Resistance, Viral/Drug Resistance, Viral/*genetics

  • Source: JAMA [JAMA] 2006 Feb 22; Vol. 295 (8), pp. 891-4. Date of Electronic Publication: 2006 Feb 02.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Changes in Prescribing of Antiviral Medications for Influenza Associated With New Treatment Guidelines.

Subjects: *ANTIVIRAL agents; *ADAMANTANE; *AMANTADINEUNITED StatesCENTERS for Disease Control & Prevention (U.S.)

  • Source: American Journal of Public Health. Oct2009 Supplement, Vol. 99 Issue S2, pS362-S364. 3p. 1 Graph.

Record details

Read Online Read More Add to Saved list
×
Editorial & Opinion

Baseline differences in the SAVOR trial.

  • Authors : Luijendijk HJ; Department of General Practice, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.; Hulshof TA

Subjects: Adamantane/Adamantane/Adamantane/*analogs & derivatives ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Dipeptides/Dipeptides/Dipeptides/*adverse effects

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2015 Dec; Vol. 17 (12), pp. 1202. Date of Electronic Publication: 2015 Jul 08.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitus.

  • Authors : Kothny W; Novartis Pharmaceuticals, East Hanover, NJ 07936, USA. ; Foley J

Subjects: Adamantane/Adamantane/Adamantane/*analogs & derivatives ; Blood Glucose/Blood Glucose/Blood Glucose/*metabolism ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2013 Mar; Vol. 15 (3), pp. 252-7. Date of Electronic Publication: 2012 Nov 01.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The design and rationale of the saxagliptin assessment of vascular outcomes recorded in patients with diabetes mellitus-thrombolysis in myocardial infarction (SAVOR-TIMI) 53 study.

  • Authors : Scirica BM; TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. ; Bhatt DL

Subjects: Adamantane/Adamantane/Adamantane/*analogs & derivatives ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Dipeptides/Dipeptides/Dipeptides/*therapeutic use

  • Source: American heart journal [Am Heart J] 2011 Nov; Vol. 162 (5), pp. 818-825.e6.Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

A protocol for active surveillance of acute myocardial infarction in association with the use of a new antidiabetic pharmaceutical agent.

  • Authors : Fireman B; Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612, USA. ; Toh S

Subjects: Adamantane/Adamantane/Adamantane/*analogs & derivatives ; Dipeptides/Dipeptides/Dipeptides/*adverse effects ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*adverse effects

  • Source: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2012 Jan; Vol. 21 Suppl 1, pp. 282-90.Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Internet ISSN: 1099-1557 (Electronic)

Record details

Read More Add to Saved list
×
Periodical

FDA approves saxagliptin for type 2 diabetes.

Subjects: Adamantane/Adamantane/Adamantane/*analogs & derivatives ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Dipeptides/Dipeptides/Dipeptides/*therapeutic use

  • Source: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2009 Sep 01; Vol. 66 (17), pp. 1513.Publisher: Oxford University Press Country of Publication: England NLM ID: 9503023 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  259 results for ""Adamantane""